PSMA PET for Surveillance After Focal Therapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

PSMA PET for Surveillance After Focal Therapy — Stella

Recruiting

Back to Prostate Cancer (Adenocarcinoma) trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois

Key details

Sponsor

University of Chicago

Collaborators

Blue Earth Diagnositcs

Enrollment target

~62 participants

Started

November 2025

Primary completion

August 2028

Age range

18 Years and older

Sex

Male only

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov